October 2013

This third and final installment emanating from our roundtable with oncology nursing experts focuses on survivorship, now universally recognized as a crucial aspect of oncology care.

Colorectal cancer is the third leading cause of cancer death among African Americans. The CRC mortality rate among African Americans is 29.8% compared with 19.5% among Caucasians.

The growing number of survivors of cancer in the United States today-nearly 14 million strong and rising-is indeed a cause for celebration.

Selecting the optimal treatment for postmenopausal patients with hormone receptor (HR)-positive metastatic breast cancer (MBC) remains a challenge, given a preponderance of data for several approved therapeutics

Registries, large databases of patient information collected in a systematic, standardized fashion, most often focus on biologic measures, such as pathology, radiology, and laboratory results, to track incidence and prevalence of disease as well as causative factors.

It's been well established now that cancer survivorship begins on the day of diagnosis. Despite the positive spin that this presents for patients, families, friends, and coworkers, most people still associate cancer survivorship with completing treatment and getting on with life.